---
$id: https://graph.org.ai/products/commodity/51131747
$type: Product
source: UNSPSC
code: "51131747"
title: "Epoprostenol sodium"
class: "51131700"
classTitle: "Thrombolytic drugs and platelet aggregation inhibitors"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Epoprostenol sodium

**UNSPSC Code**: 51131747
**Class**: [Thrombolytic drugs and platelet aggregation inhibitors](Thrombolytic drugs and platelet aggregation inhibitors.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a prostaglandin analogue and antihypertensive agent with the molecular formula C20H31O5.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4K04IQ1OF4, chemically known as u 53,217a but more generally known as epoprostenol sodium, which bears US NIH Compound Identifier 5282410. European Medicines Agency schedules Epoprostenol sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01918MIG. Most nations, for tariff and trade purposes, schedule epoprostenol sodium under HS 29375000. As of Q4 2014, EPOPROSTENOL SODIUM remains US FDA's Preferred Term for this commodity. Epoprostenol sodium bears US NLM identifiers UMLS ID C0354594 and NCI Concept Code C47514. SMILES: CCCCC[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)[O-])/O2)O)O.[NA+].

